Equity Capital Markets

Company · CIK 1737523

BioNexus Gene Lab Corp

CIK1737523 (SEC EDGAR)
Industry (SIC)8071 — Services-Medical Laboratories
Incorporated inWY
ListedBGLC (Nasdaq)
First annual or quarterly report2019-05-15

Offerings

3 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-291379
ShelfDormant
 2025-11-072025-11-071
333-269753
Registered companyFinal prospectus
 2023-02-142023-07-216
333-229399
First-time registrationEffective
 2019-01-292019-04-034

Filings

11
FiledFilingRegistrationAccession
2025-11-07S-3Shelf registered 333-2913790001477932-25-007976
2023-07-21424B4Final prospectus 333-2697530001477932-23-005483
2023-07-19EFFECTDeclared effective 333-2697539999999995-23-002131
2023-07-17S-1/AAmendment 333-2697530001477932-23-005323
2023-07-05S-1/AAmendment 333-2697530001477932-23-004992
2023-05-09S-1/AAmendment 333-2697530001477932-23-003180
2023-02-14S-1Registration filed 333-2697530001477932-23-000981
2019-04-03EFFECTDeclared effective 333-2293999999999995-19-000583
2019-03-27S-1/AAmendment 333-2293990001551163-19-000051
2019-02-25S-1/AAmendment 333-2293990001551163-19-000043
2019-01-29S-1Registration filed 333-2293990001551163-19-000018

All filings of this company · CSV